(Q36641763)

English

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group

scientific article published on May 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Skinner R

1

1 reference

Europe PubMed Central

15 August 2017

Cotterill SJ

2

1 reference

Europe PubMed Central

15 August 2017

Stevens MC

3

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

82

1 reference

Europe PubMed Central

15 August 2017

10

1 reference

Europe PubMed Central

15 August 2017

1636-1645

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1214

0 references

The long-term survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Risk factors for ifosfamide nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide nephrotoxicity in paediatric cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Albumin Excretion as a Measure of Glomerular Dysfunction in Children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide in refractory male germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Toxicity of high-dose ifosfamide in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Nephrotoxicity after ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Assessment of chemotherapy-associated nephrotoxicity in children with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Acute ifosfamide-induced proximal tubular toxic reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide in paediatric oncology: tried but not tested?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide, Fanconi's syndrome, and rickets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Reversible hypophosphatemic rickets following ifosfamide treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Iphosphamide-induced nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Progressive glomerular toxicity of ifosfamide in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Nephrotoxicity associated with ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Simplified quantification of urinary protein excretion in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Fanconi syndrome after ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Acute ifosfamide-induced tubular toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Ifosfamide in pediatric malignant solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

The impact of childhood cancer on the United States and the world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Renal function abnormalities after ifosfamide treatment in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

20 September 2018

Clinical trial of isophosphamide (NSC-109724)--results and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE GROWTH AND MATURATION OF HUMAN GLOMERULI AND PROXIMAL CONVOLUTIONS FROM TERM TO ADULTHOOD: STUDIES BY MICRODISSECTION

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function in children and adolescents following 72 g/m2 of ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postnatal development of tubular phosphate reabsorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and safety of high-dose ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose ifosfamide alone and in combination for solid malignancies in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1214

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36641763&oldid=1642897018"